Acquisition, Equity-Method Investment and Licensing Arrangements - (Tables)

6 Months Ended

Jun. 28, 2020

Business Combinations, Disposal Groups, Including Discontinued Operations, Equity Method Investments And Research And Development Arrangement [Abstract]

Equity Method Investment

Summarized financial information for our equity method investee, GSK Consumer Healthcare, as of and for the three and six months ending March 31, 2020, the most recent period available, is as follows:
(MILLIONS OF DOLLARS)	March 31, 2020
Current assets	$	8,213
Noncurrent assets	37,627
Total assets	$	45,840
Current liabilities	$	5,524
Noncurrent liabilities	5,152
Total liabilities	$	10,677
Equity attributable to shareholders	$	35,031
Equity attributable to noncontrolling interests	133
Total net equity	$	35,163

(MILLIONS OF DOLLARS)	Three Months Ended March 31, 2020			Six Months Ended  March 31, 2020
Net sales	$	3,503		$	6,691
Cost of sales	(1,394		)	(3,205		)
Gross profit	$	2,109		$	3,486
Income from continuing operations	425			471
Net income	425			471
Income attributable to shareholders	405			441